These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16781125)

  • 1. Lipid composition effect on permeability across PAMPA.
    Seo PR; Teksin ZS; Kao JP; Polli JE
    Eur J Pharm Sci; 2006 Nov; 29(3-4):259-68. PubMed ID: 16781125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system.
    Teksin ZS; Hom K; Balakrishnan A; Polli JE
    J Control Release; 2006 Nov; 116(1):50-7. PubMed ID: 17049402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid subclass specific alterations in the passive ion permeability of membrane bilayers: separation of enthalpic and entropic contributions to transbilayer ion flux.
    Zeng Y; Han X; Gross RW
    Biochemistry; 1998 Feb; 37(8):2346-55. PubMed ID: 9485381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization.
    Shimanouchi T; Ishii H; Yoshimoto N; Umakoshi H; Kuboi R
    Colloids Surf B Biointerfaces; 2009 Oct; 73(1):156-60. PubMed ID: 19560324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive diffusion of polymeric surfactants across lipid bilayers.
    Mathot F; Schanck A; Van Bambeke F; Ariën A; Noppe M; Brewster M; Préat V
    J Control Release; 2007 Jul; 120(1-2):79-87. PubMed ID: 17524515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
    Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
    Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement and in vitro evaluation of amifostine permeation through artificial membrane (PAMPA) via ion pairing approach and mechanistic selection of its optimal counter ion.
    Samiei N; Shafaati A; Zarghi A; Moghimi HR; Foroutan SM
    Eur J Pharm Sci; 2014 Jan; 51():218-23. PubMed ID: 24161609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes.
    Koljonen M; Rousu K; Cierny J; Kaukonen AM; Hirvonen J
    Eur J Pharm Biopharm; 2008 Oct; 70(2):531-8. PubMed ID: 18582575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAMPA--a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer.
    Nielsen PE; Avdeef A
    Eur J Pharm Sci; 2004 May; 22(1):33-41. PubMed ID: 15113581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
    Tam KY; Avdeef A; Tsinman O; Sun N
    J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-PAMPA: a new method for fast prediction of skin penetration.
    Sinkó B; Garrigues TM; Balogh GT; Nagy ZK; Tsinman O; Avdeef A; Takács-Novák K
    Eur J Pharm Sci; 2012 Apr; 45(5):698-707. PubMed ID: 22326705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.
    Avdeef A; Nielsen PE; Tsinman O
    Eur J Pharm Sci; 2004 Aug; 22(5):365-74. PubMed ID: 15265506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
    Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M
    Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
    Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
    Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.